Prevail

Flunixin meglumine (NSAID) paste formulation for treatment of visceral pain (colic), musculoskeletal inflammation, and fever in horses. Flunixin meglumine oral paste (1.87%). Mechanism: non-selective COX inhibitor → reduces prostaglandin and thromboxane synthesis → anti-inflammatory, analgesic, and antipyretic effects. Aminonicotinic acid derivative. FDA-approved equine oral paste formulation. Key information Equine probiotic/supplement product. Store per label. Administer as directed. Safe for regular use.

Oral paste (horses): administer via dose syringe into the back of the mouth. Once or twice daily as directed. Store at room temperature; protect from light. If a dose is missed Contact your veterinarian before giving an additional dose if one was missed.

GI: gastric and right dorsal colonic ulceration (horses). Renal: azotemia with dehydration. Tissue necrosis with perivascular injection. Do not combine with other NSAIDs or corticosteroids. See flunixin meglumine.

For animals Horses: IV only (not IM). Monitor for GI ulceration; use with caution in animals with GI disease. Monitor renal function, hydration status, and urine output. Do not use concurrently with other NSAIDs or corticosteroids. Not approved for use in food-producing animals. For people handling this medication Wear gloves when handling. Wash hands thoroughly with soap and water after handling. Flunixin paste — NSAID. Wear gloves. Avoid contact with eyes; if contact occurs, flush with water for 15 minutes and seek medical attention. Keep out of reach of children.

Contact your veterinarian or emergency clinic immediately. NSAID overdose causes GI ulceration and kidney damage.